Perspectives
This is a curated collection of scholarly and non-scholarly materials that can be found in the Scholarly Literature and Media Coverage databases that are ‘opinion-heavy.’ This collection is intended to capture the full range of thought and opinion about gene drive technologies.
Rethinking the future of mosquito control
35341Kabirul Bashar, Dr Zonaed Siddiki. Dr Zonaed Siddiki, et al., Dhaka Tribune, 2025-12-17 11:37:26.
Bangladesh is once again in the grip of a severe dengue and chikungunya crisis in 2025. Hospitals are overwhelmed, fever wards are full, and doctors are working tirelessly. Families live in fear of mosquito bites, while daily news reports chronicle rising infections and deaths. As of December 16, 2025, the Directorate General of Health Services (DGHS) has reported more than 100,000 confirmed dengue cases and 409 deaths. However, this figure represents only the tip of the iceberg, as it reflects data solely from hospitalized patients, specifically from 77 hospitals in Dhaka and reports from 64 civil surgeon offices. A substantial number of dengue patients are receiving treatment at home or in various small and large hospitals and clinics that are not included in the official count. This underscores the overwhelming pressure on the country’s health system. At the same time, the Institute of Epidemiology, Disease Control and Research (IEDCR) has recorded a resurgence of chikungunya, reporting 337 suspected cases, 153 of which were laboratory-confirmed in Dhaka between January and May 2025. Researchers estimate that the true number of chikungunya infections this year may be close to one hundred thousand. As chikungunya testing is available only in a limited number of major hospitals in Dhaka, many cases remain undiagnosed and unreported.
Gene drives, species complexes, and the risks of collateral damage
35296C. Boëte, Proc. Natl. Acad. Sci., 122. 2025-11-09 18:26:26.
The development of engineered gene drive systems continues to garner significant interest. Theoretically, these systems could spread traits in a target species (an approach known as population replacement) or eliminate a population within a few generations (population suppression). Some researchers have promoted this disruptive technology for potential applications ranging from public health (e.g., malaria control) to conservation (e.g., protection of endangered species, elimination of invasive ones) to agriculture (e.g., pest control). But in the case of a gene drive intended to target a specific species, the risk of affecting non-target species must be taken into account, and researchers must strive to minimize collateral damage. Hybridization between a target and a non-target species could result in unintended gene flow, as could the horizontal transfer of the gene drive cassette (1). While some researchers have proposed the “Target Species Complex” (TSC) framework to account for off-target effects, the concept is unlikely to provide a safeguard. Rather, it risks reframing collateral impacts as intentional outcomes, narrowing, rather than broadening, the scope of ecological and regulatory considerations. Researchers must therefore make sure to incorporate risk assessments that take into account the effects on numerous species and make a concerted effort to understand the downstream effects.
Should we edit nature?
35176David Farrier, Aeon, 2025-09-26 14:10:35.
At the end of August 1939, the German archaeologist Otto Völzing discovered around 200 fragments of carved mammoth ivory at the back of a cave in southern Germany. With war just a week away, Völzing’s find was hurriedly collected in a box, where it lay unnoticed in a museum archive for decades. It wasn’t until the 1960s, when the shards were inventoried, that something astonishing emerged out of the heap of broken pieces. They formed an incomplete figurine, with a chimeric mix of features: the body of person, and the head and forearms of a cave lion. Subsequent excavations in the 1970s found further pieces of what has come to be called the Lion-Man of Hohlenstein-Stadel. Carved from a mammoth tusk around 40,000 years ago, it is one of the earliest examples of the human capacity to imagine forms that don’t exist in nature. Every age of human history since the Lion-Man has tried to think beyond nature. In Hesiod’s Theogony, composed around 700 BCE, the chimera was a compound being with the head of a lion, the body of a dragon, and a snake’s-head tail (and an extra goat’s head protruding from its back for good measure). In W B Yeats’s poem ‘The Second Coming’ (1920), a similar ‘rough beast’ is a harbinger of ruin. In our own time, the chimeras are something different. Living things in every part of the biosphere have been forced by climate change, pollution and the spread of non-native species to adapt their bodies and behaviours to a human planet. They may not have visibly merged forms like the Lion-Man, but they do bear the impression of another species: us.
OPINION: Military Shuts Down Bill Gates Genetically Modified Mosquito Project in West Africa
35137Jon Fleetwood, Substack, 2025-09-12 15:41:16.
Last month, the military government of Burkina Faso has done what no Western regulator dared to do: it ordered the immediate termination of Bill Gates’ genetically modified mosquito project—‘Target Malaria’—and the destruction of all bioengineered insect samples inside the country. This wasn’t a health agency issuing a polite memo. It was a military crackdown on a Gates-funded scheme that released engineered mosquitoes into villages without real informed consent from the people forced to live with the consequences. The press release from Target Malaria itself admits the sequence of events. First came the release: “On 11 August 2025, one small scale release of non gene drive genetically modified male bias mosquitoes took place successfully, in accord with terms and conditions of the ANB and ANEVE permits.” Translation: genetically engineered insects were already unleashed in Burkinabè villages, exposing citizens to an irreversible genetic experiment without their consent. Then came the military order to shut it down: “On 18 August, the national authorities requested the Target Malaria team at IRSS to suspend all their activities. The IRSS team complied with the request.” Finally, the junta (a government that has taken power by military force) made it permanent: “On 22 August, the Ministry of Higher Education, Research and Innovation issued a communiqué informing ‘the Burkinabè public that it has terminated all the activities of the project Target Malaria on its territory.’” This wasn’t a pause. This was a military-ordered termination of Bill Gates’ mosquito project.
Is Gene Drive Research Losing Traction?
35023Gregory C. Lanzaro and Ana M. Kormos, The American Journal of Tropical Medicine and Hygiene, 2025-08-12 16:18:27.
Significant progress has been made in developing gene drives, especially for mosquito vectors of malaria. It is widely agreed that a critical next step in advancing this technology is to evaluate it through small-scale field trials. However, obtaining permission to move forward with these trials has stalled, threatening this potentially transformative line of research. In this paper, roadblocks delaying progress are identified from the perspective of a developer group tasked with translating this technology to the field. We suggest that groups engaged in long-running discussions about risk and the formulation of a global regulatory framework are hindering progress. This is because these groups conflate large-scale deployment with small-scale trials, which have very different risk landscapes. Here we argue that confined field trials are essential for accurately assessing risk and should be conducted soon, with regulation by authorities in the country in which they will be conducted.
Releasing GM Mosquitoes in Burkina Faso is Dangerous
35009Irina Vekcha, Countercurrents, 2025-08-02 11:03:44.
The Target Malaria project claims to be able to eradicate malaria by using gene drive technology to eliminate Anopheles mosquitoes, the malaria vectors. There are several gene drive projects around the world, targeting different species (insects, mammals, fungi, etc.), using different types of gene drives, and having different stages of the technology readiness. The details of these projects are provided in the Table 2 of the Gene Drives report, produced by ENSSER, the European Network of Scientists for Social and Environmental Responsibility. The Target Malaria project, using the CRISPR/Cas9 system for the Anopheles gambiae elimination, is the most advanced project. The project was conceived in Great Britain, at Imperial College London, in the laboratory led by Andrea Crisanti. The project experimental protocol is very complex: it comprises three phases, each phase focusing on a particular type (strain) of GM mosquitoes. Only the third phase is aiming to fight against malaria, and only this phase is based on the use of the gene drive technology. All the strains are produced by Crisanti’s team and must be imported to Burkina Faso for field trials. After importation, the mosquitoes are managed by the local Target Malaria team led by Abdoulaye Diabate; each phase should normally end with mosquito release by Diabate’s team. The project is moving forward rapidly, thanks to huge capital injections, coming primarily from the Bill Gates Foundation. The project is strongly supported by the NEPAD, New Partnership for Africa’s Development, an African Union agency. The NEPAD, which favors gene drives, has appointed ABNE, the African Biosafety Network of Expertise, to oversee Target Malaria experiment. The ABNE is funded by the Bill Gates Foundation, and the NEPAD – by the Open Philanthropy Project, one of Target Malaria’s funding sources. In 2019, within the framework of the first project phase, Target Malaria released 6,400 GM mosquitoes in the Bana village of the Burkina Faso, despite the Burkinabe civil society protests. The project is currently in its second phase, which began in March 2022, following the importation of the second-phase strain into Burkina Faso. Normally, before importing a strain for field trials, the Crisanti team conducts numerous tests to ensure the strain’s quality, and only the strain that meets all the criteria defined by the experimenter is accepted for importation. However, the project has encountered setbacks.
Controversial ‘gene-drive’ strategy could make mosquitoes hostile to malaria parasites
34977Mitch Leslie, Science, 2025-07-24 09:37:48.
To fight malaria and the mosquitoes that spread it, people have drained swamps, showered their homes with insecticides, slathered themselves in noxious repellents, hidden under netting at night, and invented the gin and tonic—as a palatable way to take the bitter antimalarial quinine. Now, researchers report in Nature that they have borrowed a weapon from the mosquitoes themselves. The team genetically engineered mosquitoes to be resistant to parasites that cause malaria by inserting a version of a gene naturally found in some of the insects. They also enlisted a genetic trick known as gene drive to speed the gene variant's spread through mosquito populations in the lab. The strategy is not ready for field testing, researchers caution. But the experiments "are elegantly designed and sound, really showing great proof of principle for driving natural variants of mosquito genes into a population," says functional geneticist Tony Nolan of the Liverpool School of Tropical Medicine, who wasn't connected to the study.
Can the world survive without mosquitoes and should we even try to find out?
34934Sowjanya Pedada, LA Post, 2025-06-17 15:08:22.
Scientists have developed gene editing technology that could wipe out malaria-carrying mosquitoes within subsequent generations, offering hope against diseases like Malaria, which kills nearly 600,000 people each year. But as field trials approach, bioethicists warn that deliberately driving a species to extinction raises profound questions about our right to reshape nature. Communities in hard-hit regions now face a difficult tradeoff: accept ecological risks or continue losing lives to preventable mosquito-borne diseases. Mosquito-borne diseases extend far beyond Malaria. Dengue infects up to 3.9 billion people annually across 132 countries, causing approximately 40,000 deaths each year. Zika, documented in 89 countries, can cause severe congenital disabilities like microcephaly. The CDC calls mosquitoes the “world’s deadliest animal,” responsible for over 700,000 deaths each year. In sub-Saharan Africa, scientists at Target Malaria have developed genetic modifications that render female mosquito offspring infertile, causing populations to collapse within a few generations in lab tests. “There are so many lives at stake,” said Alekos Simoni, a molecular biologist with the group. Their method uses male mosquitoes to spread ovary-disrupting genes throughout wild populations. Gene-driven mosquito extinction has ignited ethical debate. A recent study published in Science concluded that deliberately wiping out a species may be justifiable, but only under rare, extreme conditions. “These cases highlight the tension between the intrinsic value of a species and the benefits of eradicating a harmful pest,” said Clare Palmer, a bioethicist at Texas A&M. Environmental experts warn of ecological risks, but scientists stress that only a few mosquito species, mainly malaria-spreading Anopheles, would be targeted. “Extinction is not a likely outcome, nor even a desirable one,” said Tony Nolan of the Liverpool School of Tropical Medicine. “It’s not necessary to make the mosquito extinct to eliminate malaria.”
Gene editing, extinction and ethics: Why open conversation is key
34872Gabriela Harrod, ASU News, 2025-05-26 21:41:15.
In a new paper published in Science, researchers are challenging one of conservation’s deepest assumptions — that extinction is always a failure to be avoided. With new genome-editing tools making it technically possible to eliminate entire species, the question is no longer just scientific, but ethical: When, if ever, should we consider driving a species extinct on purpose? The study, titled “Deliberate extinction by genome modification: An ethical challenge,” brought together ethicists, conservation biologists, ecologists and social scientists to explore this complex question. ASU School of Life Sciences Professor James Collins co-authored the piece, which argues that while extinction should never be taken lightly, there may be “extremely rare and compelling” cases where it is justified. “This is a research area that is inherently counterintuitive,” Collins said. “At a time when biodiversity is more valued than ever, the idea that it could be ethically permissible to deliberately eradicate a species seems paradoxical. But we’re asking: Are there situations where it makes sense?” According to Gregory Kaebnick, a senior research scholar at The Hastings Center and the paper’s lead author, this conversation started over lunch during a National Academies meeting on gene drive research. Collins posed the idea that full extinction might mark an ethical line that genome-editing technologies shouldn’t cross. “The answer we offer in this new paper is, in effect, ‘almost, but not quite,’” Kaebnick said.
Commentary on Gene drive: Communication, hype, and the publics
34870Third World Network, GMWatch, 2025-05-26 21:35:34.
An article in the Journal of Medical Entomology critically reflects on the hype surrounding gene drive technologies, a novel self-spreading form of genetic modification that is designed to engineer entire populations of wild species. The author, a specialist in vector-borne diseases at the University of Montpellier, France, concludes that current communication around gene drives “often borders on propaganda rather than fostering a balanced, 2-way dialogue”. As such, “Research institutions must also exercise caution when promoting scientific advancements in press releases and media, ensuring that accurate, reliable information reaches the public.” The rhetoric surrounding gene drive technologies is often couched in pessimistic language regarding ‘conventional’ tools. The narrow biomedical focus of such discussions also fails to consider systemic forces of vector borne disease, and “often falls short in critically examining health policies or calling for socioeconomic changes”. The current situation however, provides instructive examples of advances in malaria control, including several countries being declared malaria-free, or reporting zero deaths in recent years. Achievements have been gained with multipronged approaches including in vector control, case surveillance, diagnostics, as well as socioeconomic improvement and implementation of poverty alleviation.
Hordes of genetically modified insects set to be released in Australia: ‘They can smell you’
34740Michael Dahlstrom, Yahoo News, 2025-04-03 17:47:00.
Dengue fever is at record levels around the globe, with this trend now beginning to be reflected in Australia as the mosquito species that carries the virus spreads. It means a simple bite could soon trigger symptoms worse than an annoying itch, with victims often experiencing pain behind the eyes, headaches, muscle aches, and nausea for over a week. Surprisingly, elsewhere in the world, one solution to combatting the spread of dengue fever is breeding more of the mosquitoes in large factories. And that’s what UK-based Oxitec is now planning to do in Australia as it partners with the country’s national science agency, the CSIRO. The company operates the world’s largest mosquito breeding factory, which is located in Brazil. Inside are boxes containing thousands of “friendly” mosquitoes that are genetically engineered so only non-biting males survive. After they’re released by local governments, they breed with wild females, and because their offspring will also be majority male, the overall population can rapidly be reduced by over 95 per cent in a few breeding cycles. Australian governments could be purchasing and releasing Oxitic’s strain of “friendly” mosquitoes in the next one to two years, if the plan receives regulatory approval.
3 reasons why the release of GM mosquitoes in Queensland is risky
34554Dr. Perran Stott-Ross, University of Melbourne, 2025-03-04 11:14:23.
The British company Oxitec, in partnership with Australia's CSIRO, has announced plans to release genetically modified (GM) mosquitoes in Queensland. The initiative aims to reduce transmission of the dengue virus, as well as other pathogens spread by the Aedes aegypti mosquito by reducing the size of the mosquito population. The announcement has received significant attention from the public – there's even a petition to the Queensland Parliament to block the release. While these mosquitoes are unlikely to cause adverse health impacts as some have suggested, there are still legitimate reasons for concern. Here is why we should be wary of releasing GM mosquitoes in Australia. Only female mosquitoes drink blood to feed their eggs, meaning only female mosquitoes spread disease to humans. The mosquitoes developed by Oxitec are a Mexican strain of Aedes aegypti, genetically engineered to express a gene that's lethal to females. This means only male mosquitoes can survive and reproduce in the wild. Male mosquitoes don’t bite so they can’t spread disease, but they can still mate with wild Australian female mosquitoes and pass on their genes – both the lethal gene and other genes naturally occur in the Mexican strain of Aedes aegypti. This technique has advantages over similar technologies because it is effective across multiple generations, making the population reduction last longer. It will also only target Aedes aegypti and won’t affect other mosquito species directly. The mosquitoes will also carry a fluorescent gene making them easy to identify. The GM mosquitoes will be sold to businesses and the public, allowing anyone in Queensland to release them on their own property. They can be raised by adding water to a container and placing it outside. Eventually, male mosquitoes will emerge to mate with the wild population. The technology is already used overseas with trials showing drastic reductions in mosquito populations, but the situation in Australia is markedly different and so carries different risks.
Mitigating dengue transmission in Africa: the need for Wolbachia-infected mosquitoes’ rollout
34211Samson Ogunlade, Adeshina Adekunle, Emma McBryde, Frontiers, 12. 2025-01-07 08:57:15.
Dengue fever is a mosquito-borne viral disease that poses a significant public health concern globally. The disease is primarily transmitted by Aedes aegypti mosquitoes and the range of clinical manifestations vary from flu-like symptoms to more serious conditions such as dengue haemorrhagic fever and dengue shock syndrome. The dengue virus (DENV) infects about 400 million people yearly, of which 50–100 million of those become symptomatic, with over 20,000 deaths. Dengue notifications are increasing in Africa. The continent's tropical and subtropical climatic conditions create a conducive breeding environment for mosquitoes and hence, contribute to the spread of the virus. While recent statistics show that there were 15.7 million reported dengue infections in 2010, recent studies show that dengue cases are on the rise in Africa. This situation presents an increasing threat to public health systems already under pressure from other infectious illnesses. Traditionally established vector control methods such as the use of insecticide, emptying or covering water-filled containers and eliminating mosquito breeding sites have had limited success in curbing the spread of dengue. This calls for experimental and innovative strategies to combat the disease effectively. One promising approach—the Wolbachia-based approach, involves the deployment of Wolbachia-infected mosquitoes into the wild mosquito population. This technique has shown great potential in reducing dengue transmission. While the Wolbachia-based technique has demonstrated highly positive results in mitigating DENV, it is not always successful—Wolbachia strategies may struggle in high temperature settings, because some mosquitoes infected with Wolbachia (such as wMel strain) are unable to transmit Wolbachia maternally to their offspring and establish themselves under high temperatures. Therefore, using thermally tolerant strains may be beneficial in establishing Wolbachia infections in mosquitoes especially in regions with high heat conditions. Although Wolbachia-infected mosquitoes have been rolled out in different countries such as Brazil, Colombia in South America; Indonesia, Taiwan, Viet Nam, Thailand, Malaysia, India in South Asia; Northern Queensland in Australia; and the United States of America, there is arguably no deployment yet made in Africa.
For the Sake of 600,000 Children, Science Must Be Bold
34053Laurie Zoloth, The New York Times, 2024-12-16 14:36:13.
Bold ideas in science research used to thrill us; now they seem pretty threatening. When I have written about the ethics of genetically engineered mosquitoes to combat malaria, many of my friends have expressed alarm. “What if it goes badly wrong?” they ask. What if there are unintended consequences that ripple across ecosystems? What if this is one of those technologies that cross the line from innovative to utterly world-destroying And yet, one could also ask, what if we do nothing? For that question, at least we have an answer. A report last week from the World Health Organization reveals that 597,000 people died of malaria last year, overwhelmingly children under age 5, and an estimated 263 million people were sickened. Thousands of families cradled a baby dying from a preventable fever; thousands of pregnancies ended in stillbirth or maternal death. For a time in the early 2000s, it seemed as if the world was gaining ground against malaria, but progress has stalled, cases have risen and the hopes for its near-elimination by 2030 have been scuttled. Global warming, armed conflict and lack of funding are all factors. And while new vaccines certainly will help, they are limited in their effectiveness (they reduce the risk of severe malaria by 30 percent and require four separate clinic visits). For much of the world’s poor, we still rely on the 19th-century technology of bed nets and insecticide. For the past two decades, scientists have explored whether a new technology known as a gene drive might hold the tantalizing promise of eliminating malaria by targeting the mosquitoes that carry the deadly parasite. The reason the gene drive is so potentially revolutionary — but disturbing — is that it uses genetic engineering to introduce changes in mosquitoes that do not stop with one generation, but are preferentially inherited by all future generations.
Opinion: A cautionary tale of experimenting with genetically modified mosquitoes in Uganda
28900Barbara Ntambirweki, The Independent, 2024-02-20 14:44:38.
The Uganda Virus Research Institute is pressing forward with gene drive technology which provides a way to rapidly, permanently, and genetically modify wild animals or plants. Gene drive organisms, are a genetically modified organism (GMO) designed to spread a genetic modification through entire populations of wild or farmed species, and are promoted as a ‘solution’ to pressing problems in the fields of public health, ecology and agriculture. The capacity of gene drives to spread and persist in the environment presents novel biosafety and socio-economic concerns for both people and biodiversity. Several research projects in Africa are advancing in their experiments to develop genetically modified ‘gene drive’ mosquitoes to release into the environment as a public health intervention to combat malaria and some are already releasing GMO mosquitoes similar to those touted by Oxitec. In Africa, Burkina Faso, Ghana, Tanzania and Uganda have allowed experimentation towards gene drive in their countries where some of these are under the auspices of Target Malaria – a consortium of research institutions led by laboratories based at Imperial College in the United Kingdom funded by Bill and Melinda Gates Foundation. In Uganda, Target Malaria has entered in partnership with the Uganda Virus Research Institute and has commenced entomological mosquito collections from field sites around Kalangala and Mukono Districts.
Otago GE Wasp Project Violates International Gene Drive Agreement
28874GE-Free NZ, Scoop, 2024-02-13 17:02:02.
Professor Dearden, Otago University, has received $11 million from the Ministry of Business, Innovation and Enterprise (MBIE) to engineer wasps using gene drive technology. He is only consulting with Māori and regulators, ignoring and side-lining the views of other concerned New Zealanders. Gene Drives using gene editing CRISPR (clustered regularly interspaced short palindromic repeat) technology. This genetic engineering causes a permanent modification of the organisms genome, which is passed on to all subsequent generations. Gene drives are designed to impact reproduction or kill the developing larvae. Due to the irreversibility of gene drives, any out-crossing across species could collapse the insect ecosystems affecting pollinators and food security. The approval of this gene drive application is a worldwide concern, as it overrides the decision on gene drives being considered at a global level through the UN Convention of Biodiversity (CBD). MBIE and researchers at the University of Otago have violated the agreement to work in unison with the international community. International concern has already been raised by the project.
Perspectives of African stakeholders on gene drives for malaria control and elimination: a multi-country survey
28750Finda, M.F., Juma, E.O., Kahamba, N.F. et al., Malaria Journal, 22:8384. 2023-12-21 15:40:51.
Gene drive modified mosquitoes (GDMMs) have the potential to address Africa’s persistent malaria problem, but are still in early stages of development and testing. Continuous engagement of African stakeholders is crucial for successful evaluation and implementation of these technologies. The aim of this multi-country study was, therefore, to explore the insights and recommendations of key stakeholders across Africa on the potential of GDMMs for malaria control and elimination in the continent. A concurrent mixed-methods study design was used, involving a structured survey administered to 180 stakeholders in 25 countries in sub-Saharan Africa, followed by 18 in-depth discussions with selected groups and individuals. Stakeholders were drawn from academia, research and regulatory institutions, government ministries of health and environment, media and advocacy groups. Thematic content analysis was used to identify key topics from the in-depth discussions, and descriptive analysis was done to summarize information from the survey data. Despite high levels of awareness of GDMMs among the stakeholders (76.7%), there was a relatively low-level of understanding of their key attributes and potential for malaria control (28.3%). When more information about GDMMs was provided to the stakeholders, they readily discussed their insights and concerns, and offered several recommendations to ensure successful research and implementation of the technology. These included: (i) increasing relevant technical expertise within Africa, (ii) generating local evidence on safety, applicability, and effectiveness of GDMMs, and (iii) developing country-specific regulations for safe and effective governance of GDMMs. A majority of the respondents (92.9%) stated that they would support field trials or implementation of GDMMs in their respective countries. This study also identified significant misconceptions regarding the phase of GDMM testing in Africa, as several participants incorrectly asserted that GDMMs were already present in Africa, either within laboratories or released into the field. Incorporating views and recommendations of African stakeholders in the ongoing research and development of GDMMs is crucial for instilling stakeholder confidence on their potential application. These findings will enable improved planning for GDMMs in Africa as well as improved target product profiles for the technologies to maximize their potential for solving Africa’s enduring malaria challenge.
ISAAA Inc. | Genetic Tools For Conservation and Health: What’s The Role of Gene Drives?
28634Kristine Grace N. Tome, Science Speaks, 2023-12-04 11:20:10.
ISAAA Inc., in partnership with the Outreach Network for Gene Drive Research and the Malaysian Biotechnology Information Centre (MABIC), gathered approximately 834 online participants during the webinar Genetic Tools for Conservation and Health: What's the Role of Gene Drives? held on November 16, 2023, via Zoom and livestreamed on Facebook and YouTube. The online session is the first of the 2023 Gene Drive Webinar Series that focuses on the interests of specific countries and aims to promote a productive and balanced conversation on the benefits and risks of possible gene drive applications relevant to national priorities. The Philippines has been picked as the first country to be engaged in the webinar series. The Philippines has been at the forefront of biotechnology research and regulation in Asia for a long time and plays an important role in shaping the region’s views on novel technologies and developing expertise.
New Techniques of Genetic Modification in Pest Control Spark Debate in Canada
28501Sandeep Kunchikor, Express Healthcare Management, 2023-11-26 09:51:07.
Scientists in Canada are urging serious discussions on the use of genetic modification as a new technique in pest control. In a recent report by the Pest Management Regulatory Agency, a branch of Health Canada that regulates pesticide use, experts argue that genetic modification could become a powerful tool as older insecticides lose their effectiveness and climate change leads to new infestations. Already, such techniques are being tested to prevent mosquitoes from spreading malaria. However, the authors of the report caution that there are many unknown variables. They claim that the consequences of releasing synthetic versions of natural organisms could be harmful and permanent.
Scientific report urges debate on genetic modification to control insect pests
28490Bob Weber, CTV News, 2023-11-18 11:21:22.
Scientists are learning to turn the genetics of insect pests against themselves, altering the genome of familiar foes in ways that give farmers and doctors new ways to fight them. The burgeoning field offers fresh hope against old scourges such as malaria. And it could provide shiny new tools as familiar insecticides lose their punch and climate change shuffles the deck. But concerns buzz the new technology like a cloud of gnats. "Genetic pest-control tools could dramatically shift our relationship with the environment, not only because of their potential impact on the ecosystem of which we are a part, but also because of their challenge to the social and cultural values that shape decisions surrounding their use," says a new report from the Council of Canadian Academies.
Gene drive in plants emerges from infancy
28152M. J. A. Awan, R. Z. Naqvi, I. Amin and S. Mansoor, Trends in Plant Science, 2023-10-18 11:43:35.
Selfish genetic elements (SGEs) display biased transmission to offspring. However, their breeding potential has remained obscure. Wang et al. recently reported a natural gene-drive system that can be harnessed to prevent hybrid incompatibility and to develop a synthetic gene-drive (SGD) system for crop improvement.
The double-edged sword effect of expanding Wolbachia deployment in dengue endemic settings
28137M. G. Pavan, G. A. Garcia, M. R. David and R. Maciel-de-Freitas, The Lancet Regional Health - Americas, 27:100610. 2023-10-02 10:16:37.
We can use Brazil as a showcase to foresee and avoid a double-edged sword effect associated with Wolbachia releases. Insecticide resistance of native Ae. aegypti populations is spread worldwide (http://aedes.irmapper.com), and positive results should boost Wolbachia deployment in other dengue endemic settings around the world. Aedes aegypti populations are heterogeneous and nationwide releases of a Wolbachia strain whose genetic backcross belong to a specific locality would produce an unsought homogenization of vector populations. Aedes aegypti homogenisation at large geographic scales could impose additional undesirable consequences in the long-term by promoting genetic hitchhiking of traits such as higher vector competence, lower susceptibility to repellents and insecticides, or more avid host-seeking and biting behaviour. Available data has shown that ensuring adherence to local characteristics, specially a matching genetic between native and released mosquitoes, is critical to enhance the likelihood of achieving a faster introgression in the field, realizing cost and time savings over the globe. Probably there are a myriad of yet undiscovered traits beyond insecticide resistance that may influence vector local adaptation and would affect the success of released strains. Therefore, neglecting the genetic diversity in favour of centralising the rearing of mosquitoes with Wolbachia for nationwide releases could represent a drawback for future releases. Long-term studies regarding the consequences of releasing mosquitoes with homogenous genotypes in diverse ecological and epidemiological scenarios remain a critical research priority, essential for informed decision-making and sustainable management of mosquito-borne diseases.
Engineered and natural gene drives: mechanistically the same, yet not same in kind
27995R. F. Medina and J. Kuzma, Nature Communications, 14:5994. 2023-09-26 08:18:08.
We propose the use of the terms natural gene drive (NGD) and engineered gene drive (EGD) arguing against James et al.1, who think both should be included within the term “gene drive”, based on their mechanistic similarities. Thanks to CRISPR-Cas-based gene editing, engineered gene drive has suddenly become feasible as a potential cost-effective pest control tool that could help us resolve wicked challenges2,3 . In nature, several organisms harbor genes that “selfishly” drive themselves into populations. This natural gene drive uses similar mechanisms to the ones use today to drive engineered genes into laboratory populations4 article we disagree with James et al.1 .In this who have recently proposed that because natural and engineered gene drives are mechanistically indistinguishable from a molecular standpoint, they should both be referred as “gene drives” because “a gene drive is a gene drive.” We instead propose that two terms be used to distinguish between natural and engineered gene drives, we second Wells and Steinbrecher5 arguments, and propose to use the terms natural gene drive (NGD) and engineered gene drive (EGD).
Unleashing the swarm: Battling the global mosquito menace and defending public health
26467J. Entine and S. Moxon, Genetic Literacy Project, 2023-07-05 07:47:22.
There is one solution embraced by global health experts that should be pursued aggressively, if with some caution. Scientists in real-world trials have altered the genomes of entire animal populations, including mosquitoes, to thwart the vectoring of diseases and control pests — an innovation called gene drives. Emerging gene drive technologies offer enormous potential and have already shown their value in test projects in many parts of the world. More recently, the application of CRISPR/Cas9 tools has dramatically accelerated their effectiveness. But implementation on a wider scale is progressing at a snail’s pace. Why? For the most part, it is restrained by controversy, misunderstanding and the political opposition of activist environmental groups in Europe and North America.
Gene Drive technologies for Malaria control in Africa: Who Should call the shots?
2023-07-05 06:08:24.Guerrilla eugenics: gene drives in heritable human genome editing
26475A. D. Cutter, J Med Ethics, 2023-07-04 08:15:56.
CRISPR-Cas9 genome editing can and has altered human genomes, bringing bioethical debates about this capability to the forefront of philosophical and policy considerations. Here, I consider the underexplored implications of CRISPR-Cas9 gene drives for heritable human genome editing. Modification gene drives applied to heritable human genome editing would introduce a novel form of involuntary eugenic practice that I term guerrilla eugenics. Once introduced into a genome, stealth genetic editing by a gene drive genetic element would occur each subsequent generation irrespective of whether reproductive partners consent to it and irrespective of whether the genetic change confers any benefit. By overriding the ability to 'opt in' to genome editing, gene drives compromise the autonomy of carrier individuals and their reproductive partners to choose to use or avoid genome editing and impose additional burdens on those who hope to 'opt out' of further genome editing. High incidence of an initially rare gene drive in small human communities could occur within 200 years, with evolutionary fixation globally in a timeframe that is thousands of times sooner than achievable by non-drive germline editing. Following any introduction of heritable gene drives into human genomes, practices intended for surveillance or reversal also create fundamental ethical problems. Current policy guidelines do not comment explicitly on gene drives in humans. These considerations motivate an explicit moratorium as being warranted on gene drive development in heritable human genome editing.
Malaria Cases In U.S. Trigger Unfounded Claims About Bill Gates, Mosquito Project
26378B. Y. Lee, Forbes, 2023-07-01 07:03:59.
When the U.S. Centers for Disease Control and Prevention (CDC) issued an alert about finding four malaria cases in Florida and one malaria case in Texas, it created quite a buzz. After all, these were the first reported cases of people actually catching malaria in the U.S. since 2003. Finding these five cases has raised questions about whether malaria may return to the U.S. after being largely absent for many years and whether climate change may be opening the gates for Anopheles mosquitoes to spread in the U.S. That would kind of suck since the females of certain Anopheles mosquito species can carry and transmit malaria-causing parasites. This news also opened the gates in another way—allowing a flood of even more conspiracy theories about billionaire philanthropist Bill Gates to be spread across social media. This included claims that Gates was somehow responsible for these new malaria cases via a project that has released genetically-modified mosquitoes in the U.S. However, such claims really provided zzzzzero supporting evidence and, in fact, detracted from what’s really happened.
Worldwide Experts on Gene Drives
Save Our Seeds, 2023-06-28 08:54:11.We are travelling the world speaking to some of the world's leading thinkers, activists and academics on the impact of gene drives. Join us for this video series as we hear from a diverse range of experts on one of the most controversial new emerging technologies that we face.
Generation game: gene-edited mosquitos to fight malaria
25551J. Opara, Sci Dev Net, 2023-06-07 08:44:49.
Population-level changes in the genetic make-up of one of the world’s deadliest animals could provide a key in the fight against malaria, proponents of a radical new technology argue. So-called gene drive technology, where genetic changes are passed down through generations, could rein in mosquito populations, or prevent them from passing on malaria.“Through genetic engineering, researchers have modified mosquitoes to favour the inheritance of genes that either will reduce the size of the population of those mosquitoes or stop them from transmitting the malaria parasite,” Michael Santos, senior vice-president and chief population health sciences officer at the US-based charity the Foundation for the National Institutes of Health (FNIH), tells SciDev.Net. “In other words, [it is about] using mosquitoes to control mosquitoes.” Malaria is one of the world’s “big three” deadly diseases, killing over half a million people in 2021, the vast majority in Africa.
Cell biology: Selfish B chromosomes unleashed by a dysfunctional chromosome segregation system
25563P. Ferree, Current Biology, 33:R431-R434. 2023-06-05 09:18:59.
A study in the fruit fly Drosophila melanogaster shows that a defective chromosome segregation system allows non-essential B chromosomes to transmit at higher-than-Mendelian frequencies.
Genetically Engineered Mosquito experiment in California’s Central Valley halted
25147H. Bourque, Friends of the Earth, 2023-05-12 14:52:46.
In a victory for environmentalists, scientists and vulnerable agricultural communities across California, the California Department of Pesticide Regulation (DPR) announced yesterday the withdrawal of a permit request for a mass release of experimental genetically engineered mosquitoes in the Central Valley. The withdrawal of the biotech corporation Oxitec’s request halts the controversial proposed release of billions of genetically engineered insects. Scientists and other experts in the field have raised concerns about Oxitec’s proposal to release genetically engineered mosquitoes due to inadequate scientific review and lack of appropriate and relevant regulations, pressuring the company to disclose data critical to assessing potential public health and environmental impacts.
Editorial: Genetic control of insect pest species—achievements, challenges, and perspectives
25423I. Häcker, D. Bartsch, A. Choo and F. Marec, Frontiers in Bioengineering and Biotechnology, 11. 2023-05-05 08:12:07.
Genetic control is a type ofbiological control and a promising approach to regulate insect pest populations in a species-specific manner. It is based on targeting the reproductive capacity of the target pest species to reduce population size to non-critical levels. The best known and also very successful genetic control strategy is the Sterile Insect Technique (SIT), which entails the continuous mass-release ofirradiation-sterilized males ofa given species to produce infertile matings in the field, leading to the decline in the target population over time. To date, SIT is only available for a few species, as its transfer to new target species is challenging and time consuming. Key aspects of this classical SIT and challenges in applying it to new pest species include mass rearing of target species, mass removal of female insects prior to irradiation and release, the sterilization procedure, and the biological quality control of the sterile insects produced. Besides this classical SIT strategy, current research efforts are also focused on the development of genetic control approaches based on transgenic, symbiont-mediated, or gene-drive strategies. Modern genetic technologies offer new solutions for the improvement of existing genetic control strategies and insect strains, for faster and easier transfer of existing strategies to new target species, and also for the development of new genetic control approaches. Publications within this Research Topic address pressing questions and challenges related to the genetic control of insect pests.
Probing “Selfish” Centromeres Unveils an Evolutionary Arms Race
24935M. Lampson, The Scientist, 2023-04-03 10:08:47.
The so-called Robertsonian (Rb) fusions that led to these rapid karyotype changes are relatively common chromosomal rearrangements. But their accumulation in the populations of Madeira Island and in multiple other isolated mouse populations elsewhere is likely due to another influencing factor: the preferential segregation of the Rb fusion into the egg rather than into the discarded polar bodies that form during female meiosis. We usually think of the chromosome segregation machinery as ensuring unbiased, random segregation. As we learn in high school biology, if a diploid individual carries two different alleles of a gene (i.e., is heterozygous), then either allele is equally likely to end up in a haploid gamete. This law explains the 3:1 ratio of phenotypes that Mendel observed in his classic studies of heredity. Scientists have known for decades, however, that selfish genes can subvert Mendelian segregation to increase their frequency in the next generation, a phenomenon known as meiotic drive. The Madeira mice suggest that fusion chromosomes can also drive unequal inheritance.
A gene drive is a gene drive: the debate over lumping or splitting definitions
24910S. L. James, D. A. O'Brochta, F. Randazzo and O. Akbari, Nature Communications, 2023-03-29 12:22:20.
Gene drive technologies are being considered as a new approach to address a variety of currently intractable global problems, including to prevent disease transmission, reduce crop loss, and preserve biodiversity1. There are some outside the genetics research community who argue that wide use of the term “gene drive” to encompass selfish genetic elements found either in extant organisms (natural gene drives) or assembled in the laboratory (synthetic gene drives) will discourage the necessary scrutiny of risks that may be associated with the introduction of synthetic gene drives into free-living populations of target organisms2,3. Here we argue that the current definition is both scientifically sound and promotes good governance.
Synthetic gene drives as an anthropogenic evolutionary force
24895A. D. Cutter, Trends in Genetics, 2023-03-28 07:24:22.
Genetic drive represents a fundamental evolutionary force that can exact profound change to the genetic composition of populations by biasing allele transmission. Herein I propose that the use of synthetic homing gene drives, the human-mediated analog of endogenous genetic drives, warrants the designation of ‘genetic welding’ as an anthropogenic evolutionary force. Conceptually, this distinction parallels that of artificial and natural selection. Genetic welding is capable of imposing complex and rapid heritable phenotypic change on entire populations, whether motivated by biodiversity conservation or public health. Unanticipated possible long-term evolutionary outcomes, however, demand further investigation and bioethical consideration. The emerging importance of genetic welding also compels our explicit recognition of genetic drive as an addition to the other four fundamental forces of evolution.
Gene Drives Are Coming
24887D. Lowe, Science, 2023-03-23 08:26:31.
Consider the “gene drive” idea - there are a lot of variations, but the general idea is that you introduce a genetic sequence into an organism that can bias (drive) its own inheritance into the next generation. This is a thumb-on-the-scale unnatural selection if ever there was one, because that biased inheritance is outside of any fitness advantage that the new sequence might bring with it. In fact, a number of gene drive ideas have the opposite sign, conferring catastrophic unfitness in order to wipe out pathogens and disease-vector organisms.Gene drives of various kinds show up in nature, though, when a gene has some sort of ability to control its own transmission. These are the so-called “selfish genes”, and some of these have no fitness advantage (or even some disadvantage) in the organisms themselves. There are a lot of potential mechanisms for this (see that link for a good review), but what you don’t see are the total-wipeout forms just mentioned, which is what we has humans might like to do to (say) mosquitos or tsetse flies. The advent of CRISPR-Cas9 technology has really brought a lot more attention to these ideas, because they make them far more possible, for better or worse.
Gene Drives: Target Malaria is underestimating the risks
24867C. Then, Testbiotech, 2023-03-17 07:55:56.
The Target Malaria consortium has for several years been planning to conduct field trials using genetically engineered mosquitoes in Burkina Faso. The aim is to transfer artificial gene constructs, i. e. the so-called ‘X-shredder’, into wild populations of the mosquitoes. This gene construct is meant to reduce the number of female offspring, and thus bring about a decline in the overall population of mosquitoes (Anopheles gambiae) known to transmit malaria. However, as recent research shows, the planned releases are based on flawed data and incorrect assumptions.
Gene Drives and Vector-Borne Diseases: A Comparative Perspective Using Malaria as a Case Study
24818S. Todi, The Takshashila Institution, 2023-03-07 15:51:15.
Gene drives are an emerging technological application to reduce the prevalence of vector-borne diseases, crop pests, and non-native invasive species. This method for vector control is currently at the research stage, with parallel community engagement programmes being carried out in African countries to raise awareness for its adoption. Yet, the risks associated with using gene drives may go beyond the communities they are deployed in. Hence, it is critical for India to understand the relevance of gene drive application in India and its neighboring countries to create effective policy measures for achieving control of vector-borne diseases. Using malaria as a case study, we argue that India currently does not require the use of gene drives to achieve control of mosquito-borne diseases. However, India should invest in research for gene drives and vaccines, while continuing with current efforts to curb vector-borne diseases. Further, India will need strong data monitoring systems to identify if any gene drive mosquitoes deployed by other countries make their way to India.
Social justice environmental activists move to block gene editing to control invasive species and promote biodiversity. Here’s why they’re misguided
24701S. Smyth, Genetic Literacy Project, 2023-02-07 12:46:02.
Control of invasive species has been extremely difficult with eradication virtually impossible. To control invasive plant species, chemicals are commonly used while in some instances removal of plants by hand, as Shiva advocates, is undertaken. Efforts to control invasive animals include poisoning and shooting. Needless to say, these ‘control techniques’ are inefficient and often harmful to the applicators. Advances in genetics potentially offer new solutions, using gene editing technology to create sterile populations. Sterility is a natural trait in mammals, which can be induced into invasive animals as a means of population control. Invasive pests can be captured, gene-edited to confer sterility in future generations and then released back into the wild. The offspring will gradually without the use of chemicals or hand labor contribute to reduced populations. Applying gene editing technologies is not an instantaneous solution, but they may be part of a long-term strategy.
Complicated expansion trajectories of insertion sequences and potential association with horizontal transfer of Wolbachia DNA
24573Y. H. Miao, D. W. Huang and J. H. Xiao, Zoological Research, 44:273-275. 2023-01-22 08:41:24.
Insertion sequences (ISs) are the simplest structural transposable elements (TEs) in prokaryotes, consisting only of a transposase coding sequence and its bilateral short terminal inverted repeats. Due to their gradually streamlined genomic construction, TEs rarely exist in the genomes of obligate endosymbionts. However, TE content, especially ISs, is abundant in the genome of Wolbachia bacteria, obligate endosymbionts widespread in arthropods and nematodes. Although IS indels are reported to affect genome structure and gene function in Wolbachia, the distribution patterns, sources, and transfer trajectories of ISs remain poorly understood. Furthermore, whether IS transposition is associated with dynamic horizontal transfer of Wolbachia DNA is still unclear. Based on distribution patterns in supergroup A Wolbachia strains, ISs accounted for 11% of the genome of the Wolbachia strain wWpum, one of the highest IS genome coverages reported for Wolbachia to date. Three types of ISs showed rapid expansion in wWpum, possibly due to horizontal transfer from other Wolbachia strain supergroups or more distant prokaryotes. We also found the first evidence that ISs can carry flanking Wolbachia sequences for transposition, resulting in the horizontal transfer of Wolbachia DNA into the eukaryotic genome, thus implying a potential association between ISs and horizontal gene transfer from endosymbionts to eukaryotes.
Gene Drives Could Fight Malaria and Other Global Killers but Might Have Unintended Consequences
24460M. Cobb, Scientific American, 2023-01-13 08:22:55.
Every year more than 600,000 people die from mosquito-transmitted malaria, most of them children under age five. Some insects that are disease vectors, such as mosquitoes, are currently expanding their range around the world, bringing new threats. Genetic engineering can fix this by permanently altering insect genes through what is known as a gene drive. This technology allows a chosen set of genes to alter an animal’s biology in some way, such as making them produce sterile offspring. The inability to reproduce then sweeps through a population, upending the laws of inheritance. The genes copy themselves exponentially from generation to generation, rapidly coming to dominate the whole population. Potentially, their careful use might save millions of lives by making mosquitoes unable to transmit malaria or by eliminating the insects entirely. The possibility of a definitive solution to major infectious diseases makes a compelling case for a such a techno fix.
CRISPR Gene Drives: A Weapon of Mass Destruction?
24336J. Ng, Medium, 2022-12-29 08:40:22.
Gene drives allow scientists to “drive” new genes — and their associated traits — into wildlife populations at unprecedented rates. Here’s a simplified explanation of how gene drives work. In normal sexual reproduction between species with two copies of chromosomes, each gene has a 50% chance of being inherited. However, there are particular DNA sequences called “selfish genes” whose frequency in the genome increases with each generation, even if this doesn’t result in an evolutionary advantage for the offspring. In 2003, biologist Austin Burt proposed a new way to use selfish genes to spread traits more efficiently through a population and ensure that offspring have a 100% probability of inheriting a particular DNA segment.
Genes drive organisms and slippery slopes
24322D. B. Resnik, R. F. Medina, F. Gould, G. Church and J. Kuzma, Pathog Glob Health, 2022-12-22 08:58:12.
The bioethical debate about using gene drives to alter or eradicate wild populations has focused mostly on issues concerning short-term risk assessment and management, governance and oversight, and public and community engagement, but has not examined big-picture- 'where is this going?'-questions in great depth. In other areas of bioethical controversy, big-picture questions often enter the public forum via slippery slope arguments. Given the incredible potential of gene drive organisms to alter the Earth's biota, it is somewhat surprising that slippery slope arguments have not played a more prominent role in ethical and policy debates about these emerging technologies. In this article, we examine a type of slippery slope argument against using gene drives to alter or suppress wild pest populations and consider whether it has a role to play in ethical and policy debates. Although we conclude that this argument does not provide compelling reasons for banning the use of gene drives in wild pest populations, we believe that it still has value as a morally instructive cautionary narrative that can motivate scientists, ethicists, and members of the public to think more clearly about appropriate vs. inappropriate uses of gene drive technologies, the long-term and cumulative and emergent risks of using gene drives in wild populations, and steps that can be taken to manage these risks, such as protecting wilderness areas where people can enjoy life forms that have not been genetically engineered.
Gene drive-mediated population elimination for biodiversity conservation. When you come to a fork in the road, take it
24281B. A. Hay and M. Guo, Proceedings of the National Academy of Sciences, 119:e2218020119. 2022-12-20 14:19:44.
How can the ability of t w2 to spread at super-Mendelian frequencies be utilized even if it is unable to directly drive the population to an unfit state? Gierus, Birand, and colleagues proposed placing Cas9 and a gRNA at a neutral position within the t haplotype. In this hybrid gene drive element, which they refer to as tCRISPR, Cas9 and the gRNA cleave and (hopefully) create loss-of-function (LOF) alleles in the male germ line of the prolactin (Prl) gene, which is required for female fertility. The goal with tCRISPR is for t-based segregation distortion in males to pump the Cas9/gRNAs cassette to high frequency within the population. The latter, through cleavage followed by inaccurate repair in males, will continuously produce LOF alleles at the independently segregating Prl locus. The hope is that the combination of t-based drive and accumulation of Prl LOF alleles will drive the population to an unfit state that contains a high frequency of infertile homozygous Prl mutant females along with some frequency of infertile homozygous t males. The combination of these two effects, they propose, could eliminate populations under a wider range of parameters than with t w2 alone
Gene editing and agrifood systems
24291FAO, FAO, 2022-12-20 09:22:56.
Gene-editing technologies represent a promising new tool for plant and animal breeding in low- and middle-income countries. They enhance precision and efficiency over current breeding methods and could lead to rapid development of improved plant varieties and animal breeds. However, as for any new technology, they have their merits and demerits. There is, as yet, no international consensus regarding if and how gene-edited organisms should be regulated, and whether their release would fall under the regulatory framework of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity. This science- and evidence-based Issue Paper on gene editing and agrifood systems presents a balanced discussion of the most pertinent aspects of gene editing, including the consequences for human hunger, human health, food safety, effects on the environment, animal welfare, socioeconomic impact and distribution of benefits. Intrinsic ethical concerns and issues of governance and regulation are addressed, and the roles of the public and private sectors, alone and in partnership, are summarized. Various scenarios are also presented for how gene editing might be used in the future to help transform agrifood systems.
Exploring the value of a global gene drive project registry
24279R. I. Taitingfong, C. Triplett, V. N. Vásquez, R. M. Rajagopalan, R. Raban, A. Roberts, G. Terradas, B. Baumgartner, C. Emerson, F. Gould, F. Okumu, C. E. Schairer, H. C. Bossin, L. Buchman, K. J. Campbell, A. Clark, J. Delborne, K. Esvelt, J. Fisher, R., Nature Biotechnology, 2022-12-15 14:15:40.
Recent calls to establish a global project registry before releasing any gene-drive-modified organisms (GDOs) have suggested a registry could be valuable to coordinate research, collect data to monitor and evaluate potential ecological impacts, and facilitate transparent communication with community stakeholders and the general public. Here, we report the results of a multidisciplinary expert workshop on GDO registries convened on 8–9 December 2020 involving 70 participants from 14 countries. Participants had expertise in gene drive design, conservation and population modeling, social science, stakeholder engagement, governance and regulation, international policy, and vector control; they represented 45 organizations, spanning national and local governmental agencies, international organizations, nonprofit organizations, universities, and district offices overseeing local vector control. The workshop aimed to gather perspectives on a central question: “In what ways could a gene-drive project registry both contribute to and detract from the fair development, testing and use of GDOs?” We specifically queried the perceived purpose of a registry, the information that would need to be included, and the perceived value of a registry. Three primary findings emerged from the discussion: first, many participants agreed a registry could serve a coordinating function for multidisciplinary and multisector work activities; second, doing so may require different design elements, depending on the target end-user group and intended purpose for that group; and third, these different information requirements lead to concerns about information sharing via a registry, suggesting potential obstacles to achieving transparency through such a mechanism. We conclude that any development of a gene-drive project registry requires careful and inclusive deliberation, including with potential end-users, to ensure that registry design is optimal.
Good news in the fight against vector-borne diseases
24175K. Magori, 2022-12-09 11:07:13.
At the turn of the century, several research groups attempted to apply modern genetic methodologies to achieve similar outcomes without the need for irradiation and the resulting fitness costs. Luke Alphey and his colleagues at Oxford University developed a dominant lethal genetic system for autocidal control in the Mediterranean fruitfly, where a transactivator causes lethality in the early developmental stages of heterozygous insects unless repressed by tetracycline. The company he funded (Oxitec Limited) successfully adapted this system in several agriculturally important pest species, as well as in Aedes aegypti and other mosquitoes. (Full disclosure: I worked at Oxitec Limited in 2007, but own no shares or have any other conflict of interest with them). While the first generation of these mosquitoes proved to successfully reduce wild-type mosquito populations, they required labor-intensive separation of male and female mosquitoes before release in close proximity. While this ensured that only non-biting male mosquitoes are released, it also limited the scalability of this approach.
No Environmental Release of Gene Drive Organisms
24114Anonymous, STOP GENE DRIVES, 2022-11-30 09:32:55.
We urge governments to prevent the environmental release of gene drive organisms and to establish a global moratorium on the release of gene drive organisms at the UN Convention on Biological Diversity (CBD). Gene drives work against natural rules of inheritance forcing nearly 100% instead of the usual 50% of offspring to inherit their genetically engineered traits. Whereas existing biosafety systems are designed to limit the spread and persistence of living modified organisms to mitigate against adverse impacts, gene drives are intended to spread genetic modifications to alter species and ecosystems. This would undermine the integrity of the UN Cartagena Protocol and international and national biosafety systems, including the procedures for Advanced Informed Agreement (AIA) of countries and Free, Prior and Informed consent (FPIC) of Indigenous Peoples and local communities.
Should we use a genetic weapon against mosquitoes carrying malaria?
23988T. H. Saey, ScienceNewsExplores, 2022-11-17 08:58:08.
In a large laboratory cage, a male mosquito carries a genetic weapon that could launch the destruction of his species. That loss could also mean the end of the parasite that causes malaria. The weapon? A self-replicating bit of DNA known as a gene drive. It’s one of the most anticipated tools being developed to stop mosquitoes from spreading diseases like malaria to humans. It’s also one of the most controversial. The gene drive interferes with the insects’ ability to reproduce. In one small lab study, it wiped out captive populations of mosquitoes in just eight to 12 generations. A larger study in outdoor cages in Terni, Italy, worked too. Within as little as five to 10 years, this gene drive could be ready to test in the wild. Researchers are eyeing Africa for the first test release. There, malaria takes a huge toll. In 2020, it sickened close to 241 million people on the continent. And most of the globe’s 670,000 malaria deaths that year were in Africa. About eight in every 10 were children, the World Health Organization says. Many tools have been made to fight the disease. There are preventive drugs, insecticide-treated bed nets and even vaccines. These efforts are helping. But mosquitoes are developing resistance to insecticides. And some anti-malaria drugs may no longer work well. “To go toward zero [cases], we need to have something that is transformational,” says Fredros Okumu. By that, he means a completely new type of strategy. Okumu is a mosquito biologist. He directs science programs at Ifakara Health Institute in Tanzania, a country in East Africa. Gene drives might be the big change people are looking for. This technology was first devised in 2015. Researchers are still refining and testing it. Other types of genetically altered mosquitoes have been released in Brazil, the United States and elsewhere. But so far, those altered genes spread slowly among wild populations. Gene drives could potentially spread to nearly every member of a species quickly. In this way, they could forever alter the species. Or even wipe it out.
Driving lessons: a brief (personal) history of centromere drive
24030H. S. Malik, Genetics, 2022-11-15 09:41:41.
Meiosis is an important specialized cell division in many eukaryotic species, including fungi, plants, and animals. Meiosis results in the production of haploid gametes starting from a diploid cell via 1 round of replication and 2 rounds of cell division. In an influential article published in 1957, Sandler and Novitski first pointed out that meiosis is also an intense battleground, in which gametes vie for evolutionary supremacy with each other, often poisoning their competition to gain a fratricidal advantage (Sandler and Novitski 1957). This competition, which they termed “meiotic drive,” operates as an evolutionary force that can cause an increase in frequency of the allele that is favored during meiotic transmission. Unlike alleles that rise in frequency because they confer a fitness advantage to their carriers, meiotic drivers can rise in frequency even while conferring significant fitness disadvantages on their carriers. Thus, meiotic drivers can be viewed as the quintessential selfish genes; it is the best interest of the rest of the genome to counteract their action to restore organismal fitness.
